Literature DB >> 20607809

Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.

Ye Sun1, Jing Tao, Geoff G Z Zhang, Lian Yu.   

Abstract

A previous method for measuring solubilities of crystalline drugs in polymers has been improved to enable longer equilibration and used to survey the solubilities of indomethacin (IMC) and nifedipine (NIF) in two homo-polymers [polyvinyl pyrrolidone (PVP) and polyvinyl acetate (PVAc)] and their co-polymer (PVP/VA). These data are important for understanding the stability of amorphous drug-polymer dispersions, a strategy actively explored for delivering poorly soluble drugs. Measuring solubilities in polymers is difficult because their high viscosities impede the attainment of solubility equilibrium. In this method, a drug-polymer mixture prepared by cryo-milling is annealed at different temperatures and analyzed by differential scanning calorimetry to determine whether undissolved crystals remain and thus the upper and lower bounds of the equilibrium solution temperature. The new annealing method yielded results consistent with those obtained with the previous scanning method at relatively high temperatures, but revised slightly the previous results at lower temperatures. It also lowered the temperature of measurement closer to the glass transition temperature. For D-mannitol and IMC dissolving in PVP, the polymer's molecular weight has little effect on the weight-based solubility. For IMC and NIF, the dissolving powers of the polymers follow the order PVP > PVP/VA > PVAc. In each polymer studied, NIF is less soluble than IMC. The activities of IMC and NIF dissolved in various polymers are reasonably well fitted to the Flory-Huggins model, yielding the relevant drug-polymer interaction parameters. The new annealing method yields more accurate data than the previous scanning method when solubility equilibrium is slow to achieve. In practice, these two methods can be combined for efficiency. The measured solubilities are not readily anticipated, which underscores the importance of accurate experimental data for developing predictive models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607809     DOI: 10.1002/jps.22251

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.

Authors:  Ting Cai; Lei Zhu; Lian Yu
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives.

Authors:  Ye Sun; Lei Zhu; Tian Wu; Ting Cai; Erica M Gunn; Lian Yu
Journal:  AAPS J       Date:  2012-03-21       Impact factor: 4.009

3.  Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo.

Authors:  Kari Nieto; Susan R Mallery; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2020-06-07       Impact factor: 5.875

4.  Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Authors:  Feng Qian; Jennifer Wang; Ruiling Hartley; Jing Tao; Raja Haddadin; Neil Mathias; Munir Hussain
Journal:  Pharm Res       Date:  2012-10       Impact factor: 4.200

Review 5.  Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.

Authors:  Jinjiang Li; Dhaval Patel; George Wang
Journal:  AAPS J       Date:  2016-11-28       Impact factor: 4.009

6.  Surface Enrichment and Depletion of the Active Ingredient in Spray Dried Amorphous Solid Dispersions.

Authors:  Zhen Chen; Kuan Yang; Chengbin Huang; Alan Zhu; Lian Yu; Feng Qian
Journal:  Pharm Res       Date:  2018-01-29       Impact factor: 4.200

7.  Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.

Authors:  Shu Li; Yiwei Tian; David S Jones; Gavin P Andrews
Journal:  AAPS PharmSciTech       Date:  2016-01-04       Impact factor: 3.246

8.  Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid.

Authors:  Meiki Yu; Joseph E Ocando; Louis Trombetta; Parnali Chatterjee
Journal:  AAPS PharmSciTech       Date:  2014-10-18       Impact factor: 3.246

9.  Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.

Authors:  Vincent Caron; Yun Hu; Lidia Tajber; Andrea Erxleben; Owen I Corrigan; Patrick McArdle; Anne Marie Healy
Journal:  AAPS PharmSciTech       Date:  2013-02-07       Impact factor: 3.246

10.  Theoretical prediction of a phase diagram for solid dispersions.

Authors:  Bin Tian; Xiaoyan Wang; Yuanyuan Zhang; Keru Zhang; Yu Zhang; Xing Tang
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.